Office of Management and Budget
FDA Withdraws Draft Guidance on CBD Enforcement Policy
After the Biden administration released a memo on Jan. 20 to all federal agencies informing them of a “regulatory freeze pending review,” the U.S. Food and Drug Administration (FDA) withdrew its “Cannabidiol Enforcement Policy; Draft Guidance for Industry.” Before it was withdrawn, the guidance was at the Office of Management and Budget (OMB) awaiting review. In ...
Don't Miss Out!
Industry Professionals
Stay Informed!
Stay informed about the latest health, nutrition, and wellness developments by signing up for a FREE subscription to Natural Practitioner magazine and digital newsletter.
Once subscribed, you will receive industry insights, product trends, and important news directly to your doorstep and inbox.


